Health Economics

Hexvix® is cost effective in the treatment and management of NMIBC8,22

  • Hexvix® and single shot mitomycin (MMC) led to a reduction in the number of TURBTs and patients requiring in-hospital admission compared to WLC27

The use of Hexvix® to assist primary TURBT is more expensive than WLC alone

  • Hexvix® combined with single shot mitomycin (MMC) led to a reduction in the number of TURBTs and patients requiring in-hospital admission compared to WLC27

Hexvix® use led to reduced healthcare costs8

health economics